The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nikkei dips as global growth concerns sap risk appetite

Tue, 22nd Jan 2019 02:46

* IMF cuts global growth forecasts

* Companies with big China exposure fall

* Totech soars after raising earnings forecast

By Ayai Tomisawa

TOKYO, Jan 22 (Reuters) - Japan's Nikkei edged lower onTuesday in choppy trade, retreating from a one-month high asinvestors took profits from recent gainers amid concerns aboutslowing global economic growth.

The Nikkei share average had dipped 0.1 percent to20,706.66 points by the midday break after moving in and out ofpositive and negative territory. It ended at over a one-monthhigh on Monday.

"There were hopes for a resolution to the trade disputebetween the United States and China lately and most peopleexpect that the two countries will reach a resolution," saidIsao Kubo, equity strategist at Nissay Asset Management.

But he added that while markets awaited more news from tradenegotiations, worries about global growth mounted.

The International Monetary Fund on Monday cut its worldeconomic growth forecasts for 2019 and 2020 due to weakness inEurope and some emerging markets, and said failure to resolvetrade tensions could further destabilise a slowing globaleconomy.

The IMF's downgrade came hours after China reported itsweakest quarterly growth since the financial crisis and itsslowest annual expansion in 28 years, with further coolingexpected this year.

Adding to sour sentiment, U.S. stock futures ,which indicate how Wall Street will likely open, fell 0.5percent. U.S. markets were closed on Monday for a holiday.

Recent gainers such as machinery makers which have largeexposure to China as well as chip-related stocks lost ground,with Fanuc Corp falling 1.4 percent, Yaskawa Electricdropping 0.9 percent and Tokyo Electronshedding 0.8 percent.

Bucking the weakness, Takeda Pharmaceutical soaredas much as 2.5 percent after Bloomberg reported that thedrugmaker is considering a sale of some emerging-market drugs,as it expands a push to cut debt after its $62 billion takeoverof Shire Plc, citing people familiar with the matter.

Air-conditioning system maker Totech Corp jumped 11percent after it raised its net profit outlook for the yearending March to 3.6 billion yen form 3.2 billion yen.

The broader Topix shed 0.2 percent to 1,562.80.Declining issues outnumbered advancing ones 1,307 to 700.(Editing by Kim Coghill)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.